Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2016

Nov 9, 2016

30681_dirs_2016-11-09_e5a94915-d94c-4d9b-92c5-fccbb387b9f4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-11-07

Reporting Person: BRADBURY DANIEL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-07 Common Stock G 12350 $0.00 Disposed 165575 Indirect